New Delhi: Covid vaccine Covaxin’s emergency use authorisation (EUA) has been further delayed by the World Health Organisation (WHO).
Sources say the global body has sent more technical queries to its manufacturer Bharat Biotech. This delay is likely to affect Indians’, especially students’, international travel plans adversely.
Sans the EUA, Covaxin will not be an accepted vaccine by most countries across the world. Despite the Bharat Biotech asserting that it has submitted all data required for clearance, WHO’s queries for the Hyderabad-base drug maker come.
“There is a procedure of submitting the documents for approval. WHO’s emergency use authorisation to Covaxin is expected soon,” Union Minister of State , Dr Bharati Pravin Pawar was quoted as saying by news agency ANI last Friday.
Earlier, Chairperson of the National Expert Group on Vaccine Administration, Dr VK Paul, had also said that WHO’s Covaxin approval was likely to come by the end of this month.
ALSO READ: PM Modi Took Covaxin, How Was He Allowed To Land In The US: Shiv Sena
